Access to world-class research infrastructure is critical to support high quality R&D activities and to improve Australia’s overall innovation output.
The National Collaborative Research Infrastructure Strategy (NCRIS) was established to provide cutting-edge instruments, facilities and expertise to enable public and private research activities. The NCRIS facilities and their experts can be accessed by Australian SMEs to solve business problems and facilitate the development of new products and services.
Australian National Fabrication Facility (ANFF)
ANFF provides micro and nano-fabrication facilities for Australian R&D. It can offer quick and easy access to facilities, professional services or academic collaborators, for the fabrication of prototype biomedical devices, such as:
- Microfluidics & point-of-care diagnostics
- Biomaterials and 3D printing
- Drug delivery
- Australian Phenomics Network (APN)
APN provides tools and animal models to support the large-scale systematic study of gene function that is critically important in the dawning era of precision medicine. Serving the fields of health genomics, basic biology, and clinical studies, phenomics enables the discovery of links between mutations and disease that will lead to new therapies. APN provides access to a package of cutting-edge technologies including:
- The production of unique mice as new disease models
- Genetically describing mouse models through DNA sequencing
- Systematically defining mouse models
- Providing open access storage through biobanking
- Curation and sharing of scientific data
Therapeutic Innovation Australia (TIA)
TIA enables researchers to translate health discoveries into clinical applications through providing access to facilities and expertise. TIA supports the development and manufacture of small molecules, proteins and cell therapies. It also provides quality documents and services including preclinical testing, molecular pathology and biostatistics.
Bioplatforms Australia builds research capabilities and expertise in the specialist fields of genomics, proteomics, metabolomics and bioinformatics. They enable Australian life science research by investing in state-of-the-art infrastructure and collaborative research projects that build ‘omic datasets relevant to Australian scientific challenges. Their infrastructure is available to researchers from both academia and industry, with capabilities including, but not limited to:
- Next generation sequencing, including human whole genome sequencing
- Genotyping/SNP analysis
- Transcriptomics, Epigenomics, Metagenomics Proteomics:
- Mass Spectrometry
- Liquid Chromatography
- Amino acid analysis
- Metabolite analysis
- Comparative genomics
- Data analysis
- Data integration and network biology
National Imaging Facility (NIF)
National Imaging Facility (NIF) is an Australian-wide collaborative network of imaging infrastructure that provides world-class imaging technologies and highly specialised expertise to research communities and industries. NIF provides access to state-of-the-art imaging capability of human, animals, plants, and materials and supports SMEs with Project Design Consultation including advice on most appropriate technologies, and:
- Animal Handling and Ethics
- Optimisation of Image Acquisition parameters
- Data Analysis & Interpretation
- Data management and curation
Microscopy Australia empowers science and innovation by making microscopes accessible to all scientists.
With the nation's largest range of high-end microscopes, we support Australian business and innovation across a wide range of industry sectors. Our dedicated experts add insight and value to your project. Hundreds of companies, from small start-ups to multinational corporations, have benefited from our services.
Microscopy Australia is a coalition of university-based facilities brought together by commonwealth (NCRIS), state government and university funding. We provide access to microscopes and expertise distributed around the nation to keep Australian companies and scientists at the forefront of global research and innovation.
We offer competitive rates and eligible businesses may receive additional discounts through the Microscopy Australia Technical Voucher Fund. Microscopy Australia has been trusted by industry and academia for over a decade. We look forward to working with you.
The Australian Synchrotron
The Australian Synchrotron is a world-class national research facility that uses accelerator technology to produce a powerful source of light – x-rays and infrared radiation – a million times brighter than the sun. The facility has ten different experimental stations, or beamlines, which harness that light so researchers can see the fundamental structure and composition of materials, on scales ranging from the atomic to the macroscopic – with a level of detail, speed and accuracy not possible in conventional laboratories. The Australian Synchrotron’s sophisticated scientific techniques provide benefits for diverse scientific and industrial fields and purposes, including:
- Biomedicine: offering new world-class diagnostic, imaging and therapeutic techniques and high throughput structural biology capabilities.
- Pharmaceuticals: analysing proteins, nucleic acids, viruses and biomimetic materials (such as artificial skin and organs) as well as conducting cell imaging, quality control monitoring, identification and assessment of the effectiveness of drug targets.
The Bio21 Institute has made significant investment in platform technology, creating critical mass in the areas of nuclear magnetic resonance spectroscopy, mass spectrometry, electron and optical microscopy, peptides and metabolomics. Their Magnetic Resonance Platform facility includes ten instruments, including the massive $5 million 800 Megahertz magnetic resonance. In addition, the Institute has a $10 million nanobiotechnology facility which includes an electron microscopy suite equipped with five high resolution electron microscopes and associated clean room facility. A stable of 12 mass spectrometers are situated throughout the complex. These key technologies provide powerful and versatile applications for the research conducted by Bio21 engineers, chemists, biologists, dental scientists, geneticists and pathologists. Research services include:
- Advanced Microscopy
- Magnetic Resonance
- Mass Spectrometry and Proteomics
- Metabolomics Australia
- Peptide Technologies
- Research Systems Infrastructure
The Macromolecular Interactions Facility (MIF)
The MIF Facility is a key platform technology resource at the University of Melbourne's Department of Biochemistry and Molecular Biology at the Bio21 Institute for the biophysical characterisation of proteins and other macromolecules. It offers state-of-the-art instruments for the analysis of protein size, shape, secondary structure, interactions and complex formation, and have been successfully exploited for the study of drug binding, intracellular aggregation processes, nanoparticles and other systems. Instruments are open to all researchers (academic or commercial) and appropriate training can be provided.